KEEP is designed to meet the unique challenges faced by [Therapy] patients. From helping patients manage complex, daily regimens to providing real-time insights for healthcare professionals, KEEP seamlessly integrates into patients’ lives, improving adherence and reducing treatment burdens.
passively capture dosing events
real time insights for manufacturers and health system partners
Key Challenge:
Managing complex regimens in oncology
KEEP’s Solution:
KEEP provides passive adherence tracking and personalized reminders, making it easier for patients to stay on track without added stress.
Key Challenge:
Reducing nurse check-ins
KEEP’s Solution:
For [Therapy], patients often struggle with managing the complexity of daily medication. KEEP makes this easier by providing seamless, passive tracking and support that fits into their routine without overwhelming them.
Key Challenge:
Managing complex regimens in oncology
KEEP’s Solution:
KEEP provides passive adherence tracking and personalized reminders, making it easier for patients to stay on track without added stress.
While real-world data captures how patients take their medication, KEEP goes beyond that with Real World Experience (RWE-X). RWE-X captures the true, human experience of living with [Condition], giving pharma companies insights into how patients navigate their day-to-day lives with their treatment. This deeper understanding allows healthcare providers to offer more personalized and timely support, ultimately improving outcomes and patient satisfaction.
Pilot Phase
In the initial pilot phase, KEEP will be deployed to a select group of patients on [Therapy] to demonstrate its impact on adherence and patient engagement.
Evaluation & Scaling
Following the pilot, we’ll assess the results and work with your team to fine-tune KEEP’s features to ensure maximum benefit for all patients on [Therapy].
Full-Scale Rollout
Once the pilot is complete, KEEP will be rolled out across all [Therapy] patients, helping you deliver improved adherence and engagement at scale.
